In a rare move, nonprofit organization Blood Cancer United is buying the remaining supplies of a discontinued investigational ...

Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.

A spate of new research suggests that GLP-1 drugs like Ozempic and Wegovy can protect you against cancers like in the lung ...

Cancer drug development has never moved faster. Yet, for too many patients, the next treatment decision still begins with ...

For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...

A distinct signaling pathway called TNF- drives the transformation of epithelial cells into aggressive tumor cells. During cancer progression, cells activate their own TNF- program and become invasive ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

GLP-1 drugs aren’t just reducing weight — they may also be reducing the chances of developing one of the most common and ...

The same cellular renewal that keeps our bodies healthy might also fuel the growth of cancer. A UC Merced biologist has found that the brain could hold the key to stopping it. Professor Néstor Oviedo, ...

A Bristol scientist is looking into a type of blood cancer after her mum fell ill with the disease.

Cancer research in cats has never received the same attention as research in people or dogs, despite the fact that cats share ...